PEMF · Compare
NeoRhythm vs Oska Pulse
The NeoRhythm edges it on disclosure: a published frequency range and app control, with an honest 'not FDA evaluated' line. The Oska Pulse publishes only a coverage area and a frequency sweep, no field figure, and its FDA-registered status is paperwork, not a clearance.
Both are affordable wearables, and neither publishes a field strength we can credit as a spec. The NeoRhythm at least discloses a wide frequency range (1 to 303 Hz) and is candid that it has no FDA clearance; the Oska Pulse publishes no field strength at all and leans on FDA-registered Class 1 status.
| $279 | Price | $399 |
| 2500 µT peak (not a spec) | Field spec | no figure |
| 1-303 Hz | Frequency | 1-150 Hz |
| not disclosed | Waveform | not disclosed |
| none claimed | FDA | registered only |
| wearable | Format | wearable |
Score breakdown
| 0.0 | Verified Field Spec30% | 0.0 |
| 1.0 | Regulatory Honesty20% | 0.0 |
| 10.0 | Frequency & Programmability15% | 1.0 |
| 3.0 | Coverage & Applicators15% | 3.0 |
| 5.0 | Value20% | 2.5 |
FAQ
- Why do both wearables score low?
- Because field spec is our heaviest dimension, and neither publishes a sustained field strength in real units at a stated frequency. They rank on programmability, coverage, FDA honesty, and value instead, which is why neither lands high.